Procurement of Ravulizumab IV Infusion

GoodsAward procedure without prior publication of a call for competition

Awarded value£400,000published contract · exc. VAT

Awarded 18 Aug 2022no call for competition

Awarded to Alexion Pharmaceuticals

What is being bought

Published requirement description

Procurement of Ravulizumab IV Infusion from Alexion Pharma UK Ltd

CPV: Medical equipments, pharmaceuticals and personal care products

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland · Belfast Health & Social Care Trust

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 9 Sept 2022, 14:09 BST
Last source update: 9 Sept 2022, 14:09 BST
Authority reference: DACPM2022-26
FTS notice number: 2022/S 000-025374
Classification (CPV): Medical equipments, pharmaceuticals and personal care products
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-03674a Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
Published justification: These essential medicines are required for continuity of patient care medicines are only available from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £400,0001 contract exc. VAT

Bids received 1

Contracts signed 1latest 18 Aug 2022

Awarded to	Value	Date	Status
Alexion Pharmaceuticals	£400,000 †	—	Awarded

Contracts

Procurement of Ravulizumab IV Infusion · Alexion Pharmaceuticals
Signed
18 Aug 2022
Value
£400,000
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authorityCentral GovernmentBody governed by public lawHealth LISBURN ROAD, BELFAST, Northern Ireland, BT97ABContact name, email

1 commercial party on the notice

Alexion Pharma UK LtdAwarded supplierGB-COH: 05970106 3 Furzeground Way, Stockley Park,, Uxbridge, South East, UB11 1EZ

Official links; attachments are not copied

No document links were published on the notice.